awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q37635256-29F12139-D4D9-468F-BCD3-742F5390CC0E
Q37635256-29F12139-D4D9-468F-BCD3-742F5390CC0E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37635256-29F12139-D4D9-468F-BCD3-742F5390CC0E
Phase II, randomized, placebo-controlled study of dovitinib in combination with fulvestrant in postmenopausal patients with HR+, HER2- breast cancer that had progressed during or after prior endocrine therapy.
P2860
Q37635256-29F12139-D4D9-468F-BCD3-742F5390CC0E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37635256-29F12139-D4D9-468F-BCD3-742F5390CC0E
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
83293decf3efd341ee152f395d0c569a65626c30
P2860
Phase 2 trial of dovitinib in patients with progressive FGFR3-mutated or FGFR3 wild-type advanced urothelial carcinoma.